Batch Release & Batch Testing Site Support Services
Ensure pharmaceutical excellence by one batch at a time
Batch Release and Batch Testing Site Support Services
We extend batch release and testing site support services to ensure your products meet high quality and compliance standards. We understand the importance of precise and timely batch release and testing, and are dedicated to supporting your success.
- Overview
We provide GMP-certified importation, batch testing, and batch release services for human, veterinary, and investigational medicinal products. With multiple QPs and MIA holders, we can perform GMP batch testing and release for sterile, non-sterile, and biological medicinal products. Most of our clients are global manufacturers without mutual recognition agreements (MRA) importing their products within the developed countries. Batch testing is mandatory before batch release, and Zenovel’s integrated solution includes batch release for these manufacturers, allowing them to entrust their products until market release.
- Method Development, Validation, Transfer
- Two EU facilities are dedicated to developing and validating analytical methods for the CMC of small molecules or biologics, which are EMA, FDA, and GMP approved.
- We use thorough procedures to transfer, validate, or create pre-qualified techniques.
- Our skilled staff, exposed to various APIs, excipients, preservatives, intermediates, & completed pharmaceutical products; often serve as the starting point for initiatives in various fields.
- Fields such as- recognition, assay evaluation, biological efficacy, dissolution tests, remnants solvents, elemental contaminants, nitrosamine and genotoxic impurity, distribution of particles size, techniques of demonstrating stability, other tests with certain CMC departments, cleaning & process validation, Orally & Nasally Inhaled Drug Products (OINDPs).
- We use GMP certified validated instrumentation for the development of analytical procedures.
- Zenovel provides GMP-certified ICH stability studies for global pharma clients, analyzing various products like tablets, capsules, ampoules, topical products, injectables, & powders.
- With walk-in climatic chambers & fully equipped laboratories, we use comprehensive method validation designs according to ICH guidelines, US and EU recommendations, & clients’ requirements.
- We have extensive experience in stability testing services.
- The test involves such as long-term, intermediate, & accelerated stability, ongoing studies, preliminary stability studies for API and FDF, development & validation of stability indicating methods, stress testing, ICH phot stability testing, leachable determination from packaging, in-use stability studies, GMP stability storage, holding time studies, temperature cycle tests, freeze-thaw, and transportation management.
- Our CMC tests for biological pharmaceuticals are designed for various customers including biotech companies, global biosimilar manufacturers, bioprocessing facilities, API producers, and fill & finish factories.
- We use an integrated orthogonal strategy and multiple methodologies to thoroughly understand the analytical fingerprint of complex compounds.
- We conduct routine quality control of biologics drugs, characterization of new biologics, comparability studies.
- Quality Control of biologics and biosimilar
- Our CMC tests for biological pharmaceuticals are designed for various customers, including biotech companies, global biosimilar manufacturers, bioprocessing facilities, API producers, and fill & finish factories.
- We use an integrated orthogonal strategy and multiple methodologies to thoroughly understand the analytical fingerprint of complex compounds.
- We conduct routine quality control of biologics drugs, characterization of new biologics, comparability studies.
- Identify root cause and implement corrective action to maintain quality and compliance in batch testing site support.
- We review necessary documents – Certificate of analysis, batch records, quality control reports for confirmation of compliance and accuracy.
- Why Choose Zenovel ?
- Expertise and Experience
Our team of professionals brings extensive experience in pharmaceutical quality control and regulatory affairs.
- Modern Facilities
We advanced testing and release services are powered by state-of-the-art laboratories and advanced technologies.
- Customer Oriented Approach
We work thoroughly with our clients to fully grasp their individual demands and then customise our offerings to fulfil those needs.
- Compliance and Integrity
Our commitment to strict regulatory standards and integrity ensures the safety and effectiveness of our products in all our operations.
People Also Ask (FAQs)
Batch release and batch testing services involve verifying that a pharmaceutical product batch meets all quality control, GMP, and regulatory requirements before it is released to the market. These services include quality testing, batch documentation review, and regulatory batch certification to ensure product safety and compliance.
Batch testing support services are essential to confirm that each batch of a pharmaceutical product meets predefined quality standards. Through quality control testing and GMP-compliant analysis, manufacturers ensure the product’s safety, efficacy, and regulatory compliance before batch release.
Pharmaceutical batch release services include batch record review, quality control verification, regulatory compliance checks, and final certification before market distribution. Zenovel supports these activities by ensuring thorough documentation review, compliance with GMP standards, and accurate batch release processes to maintain product quality and regulatory readiness.
GMP batch release services ensure compliance by reviewing manufacturing records, verifying quality control results, and confirming that production processes follow Good Manufacturing Practice (GMP) standards. This helps pharmaceutical companies maintain regulatory compliance and product quality.
Zenovel provides expert batch release regulatory support, batch documentation review, and GMP-compliant batch testing support services. Their team assists pharmaceutical companies with quality verification, regulatory compliance, and site support activities to ensure smooth and compliant batch release processes.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
